Rare diseases
Investigational molecules
Locations
Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer
PolandStudy of GHZ339 for treatment of moderate to severe atopic dermatitis
PolandStudy of efgartigimod given by IV infusion in adolescents aged 12-17 years with chronic immune thrombocytopenia
PolandStudy of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial
PolandStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
PolandStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
PolandStudy of ABBV-453 alone or with drug combination for adults with multiple myeloma: evaluation of safety and effectiveness
PolandStudy of Port Delivery System with ranibizumab given every 36 weeks in patients with neovascular age-related macular degeneration
PolandStudy of visugromab and nivolumab with or without docetaxel as second-line treatment for patients with metastatic non-squamous non-small cell lung cancer
PolandStudy of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies
PolandEvaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function
PolandEffectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
